Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial
- 1 February 2002
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 359 (9307), 663-666
- https://doi.org/10.1016/s0140-6736(02)07812-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Lack of angiotensin II–facilitated erythropoiesis causes anemia in angiotensin-converting enzyme–deficient miceJournal of Clinical Investigation, 2000
- Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxiaKidney International, 2000
- Angiotensin II stimulates proliferation of normal early erythroid progenitors.Journal of Clinical Investigation, 1997
- INTERFERENCE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS ON ERYTHROPOIESIS IN KIDNEY TRANSPLANT RECIPIENTSTransplantation, 1997
- Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.Journal of Clinical Investigation, 1996
- Statistics notes: Calculating correlation coefficients with repeated observations: Part 1--correlation within subjectsBMJ, 1995
- Association of Post-Renal Transplant Erythrocytosis and Microalbuminuna: Response to Angiotensin-Converting Enzyme InhibitionAmerican Journal of Nephrology, 1995
- Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathyKidney International, 1991
- Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.Journal of Clinical Investigation, 1990
- The origin of proteinuria at high altitudePostgraduate Medical Journal, 1987